| Literature DB >> 18200001 |
N Sugano1, S Wakino, T Kanda, S Tatematsu, K Homma, K Yoshioka, K Hasegawa, Y Hara, Y Suetsugu, T Yoshizawa, Y Hara, Y Utsunomiya, G Tokudome, T Hosoya, T Saruta, K Hayashi.
Abstract
T-type calcium channel blockers have been previously shown to protect glomeruli from hypertension by regulating renal arteriolar tone. To examine whether blockade of these channels has a role in protection against tubulointerstitial damage, we used a stereo-selective T-type calcium channel blocker R(-)-efonidipine and studied its effect on the progression of this type of renal injury in spontaneously hypertensive rats that had undergone subtotal nephrectomy. Treatment with racemic efonidipine for 7 weeks significantly reduced systolic blood pressure and proteinuria. The R(-)-enantiomer, however, had no effect on blood pressure but significantly reduced proteinuria compared to vehicle-treated rats. Both agents blunted the increase in tubulointerstitial fibrosis, renal expression of alpha-smooth muscle actin and vimentin along with transforming growth factor-beta (TGF-beta)-induced renal Rho-kinase activity seen in the control group. Subtotal nephrectomy enhanced renal T-type calcium channel alpha1G subunit expression mimicked in angiotensin II-stimulated mesangial cells or TGF-beta-stimulated proximal tubular cells. Our study shows that T-type calcium channel blockade has renal protective actions that depend not only on hemodynamic effects but also pertain to Rho-kinase activity, tubulointerstitial fibrosis, and epithelial-mesenchymal transitions.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18200001 DOI: 10.1038/sj.ki.5002793
Source DB: PubMed Journal: Kidney Int ISSN: 0085-2538 Impact factor: 10.612